Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 40 Pancreatic Neoplasms 17 Breast Neoplasms 17 Esophageal Neoplasms 14 Neoplasms 13 Stomach Neoplasms 12 Lung Neoplasms 12 Triple Negative Breast Neoplasms 11 Rectal Neoplasms 11 Neoplasm Metastasis 11 Esophageal Squamous Cell Carcinoma 11 Uterine Cervical Neoplasms 10 Colorectal Neoplasms 10 Small Cell Lung Carcinoma 9 Ovarian Neoplasms 9 Head and Neck Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Nasopharyngeal Carcinoma 5 Leukemia, Myeloid, Acute 5 Endometrial Neoplasms 5 Recurrence 4 NSCLC 4 Mouth Neoplasms 4 Colonic Neoplasms 4 Lymphoma 3 Glioma 3 Cholangiocarcinoma 3 Adenocarcinoma Of Esophagus 3 Urinary Bladder Neoplasms 2

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × HER2 Negative Breast Cancer × Drug Therapy × Clear all

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡